The second most common goal of the multimodal prediction models was to predict the stage of AD (N = 26; 18.8%), followed by the prediction of the presence of amyloid, tau, or neurodegeneration (N = 19; 13.8%), and differentiating AD dementia from other types of dementia (N = 13; 9.4%). Here, MAPT is linked to Alzheimer disease.